Perioperative Case Series: Qualitative Evaluation of Gait Cycle and Ground in Knee Arthroplasty Patients
NCT ID: NCT04268680
Last Updated: 2020-04-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
6 participants
OBSERVATIONAL
2017-11-07
2018-06-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this pilot study is to investigate which how TKA arthroplasty may impact gait during early and medium term rehabilitation phase. This will be done through the use of the OpenGo Sensor Insole (Moticon GmbH).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Kinematic Parameters to Predict Knee Diseases.
NCT03130400
Spatiotemporal Characteristics and Multi-body Dynamics Modeling Information After ACL Rupture and Reconstruction
NCT04462432
Effect of Early Gait Training on Knee Cartilage Degeneration After Anterior Cruciate Ligament Reconstruction
NCT06368544
The Influence of Running to ACL Deficiency
NCT03135600
Gait Asymmetry Assessed Using Portable Gait Analysis System
NCT02489188
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The present study is aimed at performing a preliminary evaluation to provide:
More advanced insight into a patient's functional recovery and rehabilitation with the potential for phisician's to intervene earlier and with greater specificity to any challenges encountered by the patient Objective evidence of the quality and value of the intervention on an individualized basis. Study objectives Any change in gait as a result of arthroplasty and dynamics of gait recovery during acute recovery and rehabilitation timeframe. Outcome measures will be gait cycle and ground: foot interaction dynamics which will be observed longitudinally and compared to the healthy contralateral limb (ground: foot interaction dynamics) as well literature data (gait cycle).
Primary objective:Evaluation of gait cycle and ground in primary TotalKneeArthroplasty patients compared to the healthy contralateral limb.
Secondary objectives:Easy of use. Qualitative user (Phisician and patient) feedback on experience using and wearing the insoles Study design:This is, single arm, prospective, single center, pilot study to measure the pre-operative and post-operative gait and ground: foot interaction dynamics of 6 subjects who are undergoing TotalKneeArthroplasty .
Data that will be collected at baseline (pre-op) besides the standard clinical data (VisualAnalogueScale, KneeSocietyScore SatisfactionForm-12, Knee Injury and Osteoarthritis Outcome Score(KOOS)) include: gait and ground: foot interaction dynamics during a prescribed in clinic activity as well as during activities of daily living.
Data that will be collected about the clinical follow-up include: gait and ground: foot interaction dynamics during a prescribed in clinic activity as well as during activities of daily living; user feedback regarding their experience using and wearing the insoles.
Total study duration for study participants will be 6 months with follow-up visits planned at: daily until discharge, 1 week, 2 weeks, 3 weeks, 3 months and 6 months. Full enrollement is estimated to require 1 months, therefore the total study duration is expected to be 7 months.
Subjects will be included in 1 Italian site. Data and user feedback will be analyzed continuously as they become available throughout the study period.
Patients selection:Once a subject has completed the informed consent procedure and signed the Informed Consent Form, the PI or delegated study research staff can complete the screening process with the subject. All potential subjects who undergo the screening process will be documented on a Screening and Enrollment Log, on which reasons for exclusion from or denial to participate should be noted.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 45-75 years of age (included)
* skeletally mature
* willing and able to participate in required pre-op and follow-up visits at the investigational site and to complete study procedures and questionnaires
* consented to participating in the study by signing the IRB/EC approved informed consent form
* BMI \<32
Exclusion Criteria
* Significant comorbidities that would impede the patients ability to participate in standard recovery and rehabilitation
45 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Michele Ulivi, Dr
Role: PRINCIPAL_INVESTIGATOR
IRCCS Istituto Ortopedico GaleazziMilano
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Istituto Ortopedico Galeazzi
Milan, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OpenGO
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.